Post Holdings to Acquire Weetabix for £1.4 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Post Holdings (POST) PT Raised to $105 at Pivotal Research Following Announced Weetabix Acquisition
April 18, 2017 10:45 AM EDTPivotal Research raised its price target on Post Holdings (NYSE: POST) to $105.00 (from $95.00) while maintaining a Buy rating following the company's announced acquisition of Weetabix Ltd. for $1.778 billion. POST also pre-announced 2Q earnings results at $228 million EBITDA on $1.25 billion of sales, both in-line... More
